We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Probes King Pharmaceuticals In Antitrust Inquiry

Law360 (May 10, 2006, 12:00 AM EDT) -- As part of its investigation into the potential anti-competitive effects of authorized generics of brand-name drugs, the Federal Trade Commission has requested information from King Pharmaceuticals Inc. related to a patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.